| 10.08.2021

Neutralizing the SARS-CoV-2 sugar coat

Researchers identify two sugar-binding proteins that impede the viral entry of circulating SARS-CoV-2 variants. The team, spearheaded…

| 02.07.2021

IMBA congratulates Maria Leptin

Professor Maria Leptin, a long-term member of the IMBA Scientific Advisory Board, was appointed as the next President of the…

| 02.06.2021

Colouring tumours reveals their bad influence

Red2Onco, an innovative genetic mouse model, allows to detect the very initial steps that lead to cancer development. Red2Onco’s…

| 25.05.2021

Harnessing Next Generation Sequencing to detect SARS-CoV-2 and prepare for the next pandemic

Researchers at the Vienna BioCenter designed a testing protocol for SARS-CoV-2 that can process tens of thousands of samples in less…

| 20.05.2021

Cardioids – Heartbeat, heartbreak and recovery in a dish

Self-organizing heart organoids developed at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – are…

Twitter

Download

Facts and Figures

IMBA Fact Sheet

 

Press Contact

Sylvia Weinzettl

Senior Relationship Manager
+43 1 79044-4403
sylvia.weinzettl@imba.oeaw.ac.at

Daniel Azar

Communications Officer
+43 1 79044-3821
daniel.azar@imba.oeaw.ac.at